Q-omics provides the consensus-scored MTATP6P9 profile across patient tissues and cancer cell-line models. MTATP6P9 expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in LUAD. Additionally, MTATP6P9 RNA expression shows 4,166 significant gene co-expression associations, with the highest sampling consensus in PCPG. Together, these results highlight LUAD, and PCPG as cancer lineages where MTATP6P9 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTATP6P9 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTATP6P9 survival associations across molecular data types. MTATP6P9 RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTATP6P9 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	11	LUAD (120)	view →

This table ranks reproducible MTATP6P9 RNA expression–survival associations across cancer types. High MTATP6P9 expression shows unfavorable associations in LUAD, ACC, ESCA, LUSC, KIRC and SARC. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUAD as the clearest survival context for MTATP6P9 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.400	0.816	<.001	120	view →
ACC	OS	Tertile	III,IV	0.145	0.766	<.001	63	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
LUSC	DFS	Tertile	II,III,IV	0.149	0.760	<.001	36	view →
KIRC	DFS	Tertile	IV	0.106	0.640	<.001	36	view →
SARC	OS	Tertile	All	0.148	0.518	.011	24	view →

Pink = unfavorable, green = favorable. all 11 lineages →

MTATP6P9-LUAD (OS)

Kaplan–Meier survival curve for MTATP6P9 RNA expression in LUAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTATP6P9 in patient tissues and cancer cell lines. In patient samples, MTATP6P9 shows the broadest associations at the RNA and protein expression levels, with PCPG recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	4,166	PCPG (1435)	view →
Function (RNA)	2,915	STAD (1676)	view →